Evidence map›Paper›PMID 36868102›Full record

ArticleGeneral hospital psychiatry

Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.

Yasuharu Tokuda, Peter B Barnett, Shohei Sanji, Yu Takaizumi, Misa Tomono, Haruka Tokuda, Kiyosu Taniguchi, Kenji Shibuya

Open access · hybridAbstract read
In one paragraph

Article in General hospital psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Yasuharu TokudaUniversity of Tsukuba School of Medicine, Ibaraki, Japan; Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan. Electronic address: yasuharu.tokuda@gmail.com.
Peter B BarnettUniversity of Nevada School of Medicine, Reno, USA.
Shohei SanjiCenter Hospital of the National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssanji@hosp.ncgm.go.jp.
Yu TakaizumiThe Jikei University School of Medicine, Tokyo, Japan. Electronic address: h30ms-takaizumi@jikei.ac.jp.
Misa TomonoThe Jikei University School of Medicine, Tokyo, Japan. Electronic address: h30ms-tomono@jikei.ac.jp.
Haruka TokudaUniversity of the Ryukyus School of Medicine, Okinawa, Japan.
Kiyosu TaniguchiNational Hospital Organization Mie National Hospital, Mie, Japan; Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan.
Kenji ShibuyaTokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan.
Jikei University School of Medicine · JPNational Center for Global Health and Medicine · JPThe University of Tokyo · JPTokyo National Hospital · JPUniversity of Nevada, Reno · USUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe association of serious mental illness (affective or non-affective psychotic disorders) with higher mortality in patients infected with acute coronavirus disease 2019 (COVID-19) has been suggested. Although this association remains significant after adjusting for medical comorbidities in previous studies, admission clinical status and treatment modalities should be considered as important confounding factors.

methodsWe aimed to assess whether serious mental illness is associated with in-hospital mortality, in patients with COVID-19 by adjusting for comorbidities, admission clinical status, and treatment modalities. Our nationwide cohort in Japan included consecutive patients admitted to 438 acute care hospitals for laboratory-confirmed acute COVID-19 from January 1, 2020 to November 30, 2021.

resultsOf 67,348 hospitalized patients (mean [standard deviation] age, 54 [18.6] years; 3891 [53.0%] female), 2524 patients (3.75%) had serious mental illness. In-hospital mortality was 282/2524 (11.17%) among patients with serious mental illness, while it was 2118/64,824 (3.27%) in other patients. In the fully adjusted model, serious mental illness was significantly associated with in-hospital mortality (odds ratio, 1.49; 95% CI, 1.27-1.72). E-value analysis confirmed the robustness of the results.

conclusionSerious mental illness remains a risk for mortality in acute COVID-19 after adjusting for comorbidities, admission clinical status, and treatment modalities. Vaccination, diagnosis, early assessment and treatment should be prioritized for this vulnerable group.

Indexed as

COVID-19Mental DisordersFemaleHospital MortalityHumansJapanMaleMiddle AgedSARS-CoV-2COVID-19In-hospital mortalityMental illnessPsychotic disorderSARS-CoV-2

Identifiers

PMID36868102
PMCPMC9894824
OpenAlexW4319792593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.